Drug intelligence / Profile preview

DLMR01

Development stage
Unknown
Lead developer
DexLevo
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intradermal
01

Overview

DLMR01 is a novel, liquid, particle-free polycaprolactone (PCL)-based dermal filler developed by Dexlevo for aesthetic applications, specifically the correction of crow's feet and facial rejuvenation. Unlike traditional PCL fillers that utilize microparticles suspended in a carrier gel (which can lead to complications such as needle occlusion, nonhomogeneity, or granuloma formation), DLMR01 is formulated as a fully solubilized, homogeneous liquid. Upon injection, the filler spreads naturally into the surrounding tissue and acts as a biostimulator, inducing a controlled biological response that activates fibroblasts to promote neocollagenesis (the synthesis of new collagen). This process restores skin volume, elasticity, and thickness over time. Marketed under the brand name GOURI, DLMR01 has demonstrated non-inferiority to polynucleotide-based fillers in clinical trials for wrinkle improvement.

Brand names
GOURI
Other names
liquid polycaprolactonePCL fillerpolycaprolactone-based dermal filler

Beyond the preview

Go deeper on DLMR01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DLMR01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call